Correction to: Early sepsis markers in patients admitted to intensive care unit with moderate‑to‑severe diabetic ketoacidosis

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2110-5820
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Correction to: Early sepsis markers in patients admitted to intensive care unit with moderate‑to‑severe diabetic ketoacidosis ; volume:10 ; number:1 ; day:2 ; month:6 ; year:2020 ; pages:1 ; date:12.2020
Annals of intensive care ; 10, Heft 1 (2.6.2020), 1, 12.2020

Creator
Blanchard, Florian
Charbit, Judith
Van der Meersch, Guillaume
Popoff, Benjamin
Picod, Adrien
Cohen, Regis
Chemouni, Frank
Gaudry, Stephane
Bihan, Helene
Cohen, Yves
Contributor
SpringerLink (Online service)

DOI
10.1186/s13613-020-00691-7
URN
urn:nbn:de:101:1-2020080323470264312273
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
10.08.2028, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Blanchard, Florian
  • Charbit, Judith
  • Van der Meersch, Guillaume
  • Popoff, Benjamin
  • Picod, Adrien
  • Cohen, Regis
  • Chemouni, Frank
  • Gaudry, Stephane
  • Bihan, Helene
  • Cohen, Yves
  • SpringerLink (Online service)

Other Objects (12)

Early sepsis markers in patients admitted to intensive care unit with moderate-to-severe diabetic ketoacidosis

Early sepsis markers in patients admitted to intensive care unit with moderate-to-severe diabetic ketoacidosis

Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis

Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis

Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review

Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review

Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia

Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia

Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis

Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis

Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review

Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review

Teprotumumab: The Dawn of Therapies in Moderate-to-Severe Thyroid-Associated Ophthalmopathy

Teprotumumab: The Dawn of Therapies in Moderate-to-Severe Thyroid-Associated Ophthalmopathy

Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis

Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis

MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review

MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review

Incidence and outcome of adults with diabetic ketoacidosis admitted to ICUs in Australia and New Zealand

Incidence and outcome of adults with diabetic ketoacidosis admitted to ICUs in Australia and New Zealand

Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year

Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year

Prevalence of moderate-to-severe TR suitable for percutaneous intervention in TTE patients

Prevalence of moderate-to-severe TR suitable for percutaneous intervention in TTE patients

Related objects